Toxoplasma gondii
publication ID |
https://doi.org/10.1186/s13071-024-06610-0 |
persistent identifier |
https://treatment.plazi.org/id/03996048-F129-ED2D-FC8E-FA5A42EC6D33 |
treatment provided by |
Felipe |
scientific name |
Toxoplasma gondii |
status |
|
Glabridin inhibits T. gondii growth in vitro
To assess the toxicity of glabridin on Vero cells in vitro, a CCK-8 assay was performed. Te results, shown in Fig. 1a View Fig , demonstrated that glabridin exhibited dosedependent cytotoxicity after 24 h. Specifically, at the concentration of 5 μg/ml, Vero cell growth remained at 99.05% of the control (P> 0.05). In contrast, exposure to 7.5 μg/ml of glabridin reduced the growth rate to 74.0% (P <0.0001). Tus, glabridin is considered safe for Vero cells at concentrations ≤ 5 μg/ml.
To evaluate the anti- T. gondii activity of glabridin, we examined the proliferation of RH strain tachyzoites treated with 5 μg/ml glabridin or 0.1% DMSO (vehicle). As shown in Fig. 1b View Fig , glabridin significantly (P <0.0001) inhibited the extracellular activity of T. gondii tachyzoites in a time-dependent manner. Additionally, we assessed its effects on intracellular parasites. Host cells were infected with RH tachyzoites for 3 h, after which extracellular parasites were removed, and fresh media containing either 0.1% DMSO or glabridin was added. After 48 h of culture, glabridin significantly reduced the growth of intracellular T. gondii tachyzoites, as shown in Fig. 1c View Fig (P <0.0001).
No known copyright restrictions apply. See Agosti, D., Egloff, W., 2009. Taxonomic information exchange and copyright: the Plazi approach. BMC Research Notes 2009, 2:53 for further explanation.